ClinicalTrials.Veeva

Menu
B

BRCR Global | Katy, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Upadacitinib
Dupilumab
Fruquintinib

Parent organization

This site is a part of BRCR Global

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Enrolling
Atopic Dermatitis
Drug: Upadacitinib 30mg Dose
Drug: Upadacitinib 15mg Dose

High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whethe...

Enrolling
Colorectal Cancer
Drug: Fruquintinib

Trial sponsors

AbbVie logo
Takeda logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems